VMD Pengajuan SEC - Viemed Healthcare, Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

LEI	254900XU539S8GOIOW89
CIK	1729149

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Viemed Healthcare, Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

August 12, 2025	EX-FILING FEES	Table 1: Newly Registered Securities Calculation of Filing Fee Tables S-8 VIEMED HEALTHCARE, INC. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common shares, no par value Other 412,351 $ 6.90 $ 2,845,221.90 0.0001531 $ 435.60 Total Offering Amounts: $
August 12, 2025	S-8	As filed with the Securities and Exchange Commission on August 12, 2025. As filed with the Securities and Exchange Commission on August 12, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VIEMED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) British Columbia, Canada N/A (State or Other Jurisdiction of Incorporation or Organizatio
August 6, 2025	EX-99.1	VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS Lafayette, Louisiana (August 6, 2025) Viemed Healthcare, Inc.
August 6, 2025	EX-99.2	Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care August 6, 2025 1 Second Quarter 2025 Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-l viemedq22025supplementa Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care August 6, 2025 1 Second Quarter 2025 Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U.
August 6, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2025 Viemed Healthcare, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
August 6, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO S UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
July 2, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2025 Viemed Healthcare, I UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm
July 2, 2025	EX-99.1	VIEMED COMPLETES ACQUISITION OF LEHAN’S MEDICAL EQUIPMENT ANTICIPATES UPDATING ITS FULL YEAR 2025 OUTLOOK FOR THE ACQUISITION WITH SECOND QUARTER 2025 FINANCIAL RESULTS VIEMED COMPLETES ACQUISITION OF LEHAN’S MEDICAL EQUIPMENT ANTICIPATES UPDATING ITS FULL YEAR 2025 OUTLOOK FOR THE ACQUISITION WITH SECOND QUARTER 2025 FINANCIAL RESULTS LAFAYETTE, Louisiana (July 2, 2025) Viemed Healthcare, Inc.
June 9, 2025	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm
June 9, 2025	EX-99.1	VIEMED HEALTHCARE ANNOUNCES SHARE REPURCHASE PROGRAM VIEMED HEALTHCARE ANNOUNCES SHARE REPURCHASE PROGRAM LAFAYETTE, La., (June 9, 2025) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that its Board of Directors has authorized a share repurchase program, effective through June 2026. Under the share repurchase program, Viemed may purchase
June 9, 2025	EX-10.1	Second Amendment to Credit Agreement dated November 29, 2022, among Viemed Inc. as borrower, certain subsidiaries of Viemed, Inc., as guarantors, the lenders from time to time party thereto, and Regions Bank, as administrative agent and collateral agent, effective June 6, 2025. SECOND AMENDMENT THIS SECOND AMENDMENT (this “Amendment”) dated as of June 6, 2025 to the Credit Agreement referenced below is by and among VIEMED, INC.
June 9, 2025	EX-99.2	Leading the Healthcare Industry in Home Respiratory Care Investor Presentation: NASDAQ: VMD June 2025 VieMed Healthcare Inc. • Investor Presentation Disclaimers VieMed Healthcare Inc. • Investor Presentation Disclaimers and Other Important Informatio Leading the Healthcare Industry in Home Respiratory Care Investor Presentation: NASDAQ: VMD June 2025 VieMed Healthcare Inc.
June 5, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Viemed Healthcare, I UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm
June 5, 2025	EX-10.1	Amendment to the 2024 Long Term Incentive Plan, effective June 5, 2025 FIRST AMENDMENT VIEMED HEALTHCARE, INC. 2024 LONG TERM INCENTIVE PLAN (Effective June 6, 2024) The Viemed Healthcare, Inc. 2024 Long Term Incentive Plan (the “Plan”) is hereby amended, effective June 5, 2025, if approved by the Company’s shareholders at the annual general and special meeting of shareholders on June 5, 2025, for Awards granted after the effective date as follows: 1. The first sente
May 7, 2025	EX-99.1	VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS LAFAYETTE, Louisiana (May 7, 2025) Viemed Healthcare, Inc.
May 7, 2025	EX-10.1	Executive Employment Agreement dated effective June 3, 2019 by EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement) is entered into effective June 3, 2019 (the “Effective Date”), by and between Trae P.
May 7, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2025 Viemed Healthcare, In UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
May 7, 2025	EX-10.2	Executive Employment Agreement dated effective EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (the "Agreement”) is entered into effective August 1, 2022 (the "'Effective Date”), by and between Jeremy Trahan (the "Executive”) and Sleep Management.
May 7, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
May 7, 2025	EX-99.2	Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care May 7, 2025 1 First Quarter 2025 Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looki Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care May 7, 2025 1 First Quarter 2025 Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U.
May 6, 2025	EX-99.1	VIEMED EXECUTES DIVERSIFICATION STRATEGY WITH $26 MILLION ACQUISITION OF HOME EQUIPMENT PROVIDER IN ILLINOIS VIEMED EXECUTES DIVERSIFICATION STRATEGY WITH $26 MILLION ACQUISITION OF HOME EQUIPMENT PROVIDER IN ILLINOIS LAFAYETTE, Louisiana (May 6, 2025) Viemed Healthcare, Inc.
May 6, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
April 25, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ______________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
April 25, 2025	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ______________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State
April 14, 2025	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 14, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
March 18, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
March 18, 2025	EX-99.1	Leading the Healthcare Industry in Home Respiratory Care Investor Presentation: NASDAQ: VMD March 2025 VieMed Healthcare Inc. • Investor Presentation Disclaimers VieMed Healthcare Inc. • Investor Presentation Disclaimers and Other Important Informati Leading the Healthcare Industry in Home Respiratory Care Investor Presentation: NASDAQ: VMD March 2025 VieMed Healthcare Inc.
March 10, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
March 10, 2025	EX-19.1	icy, dated January 21, 2025. VIEMED HEALTHCARE, INC. INSIDER TRADING POLICY DATED: JANUARY 21, 2025 PURPOSE OF THIS POLICY The purpose of this insider trading policy (the “Policy”) of VieMed Healthcare, Inc. (the “Company”) is to provide guidelines with respect to transactions in Company Securities and the handling of confidential information about the Company and any Subsidiary and the companies with which the Company or any
March 10, 2025	EX-99.2	Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care March 10, 2025 1 Fourth Quarter & Full Year 2024 Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitut Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care March 10, 2025 1 Fourth Quarter & Full Year 2024 Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U.
March 10, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa
March 10, 2025	EX-99.1	VIEMED HEALTHCARE ANNOUNCES RECORD 2024 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES RECORD 2024 FINANCIAL RESULTS Lafayette, Louisiana (March 10, 2025) Viemed Healthcare, Inc.
March 10, 2025	EX-21.1	Subsidiaries of the Registrant. EXHIBIT 21.1 List of Subsidiaries Name Jurisdiction of Formation Viemed, Inc. Delaware Home Sleep Delivered, L.L.C. Louisiana Sleep Management, L.L.C. Louisiana Viemed Clinical Services, LLC Louisiana Viemed Healthcare Staffing, LLC Louisiana Viemed Real Estate Holdings, LLC Louisiana Home Medical Products, Inc. Tennessee Schofield Homecare Services, Inc. Alabama Spirocare DME, LLC Tennessee East
November 12, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 November 12, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (
November 12, 2024	EX-99.1	Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD November 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed” or the “Co Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD November 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc.
November 6, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2024 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (
November 6, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare,
November 6, 2024	EX-99.1	VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS Lafayette, Louisiana (November 6, 2024) Viemed Healthcare, Inc.
August 14, 2024	EX-99.1	Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD August 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed” or the “Comp Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD August 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc.
August 14, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 14, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
August 12, 2024	S-8	As filed with the Securities and Exchange Commission on August 12, 2024. As filed with the Securities and Exchange Commission on August 12, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VIEMED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) British Columbia, Canada N/A (State or Other Jurisdiction of Incorporation or Organizatio
August 12, 2024	EX-FILING FEES	Calculation of Filing Fee Tables Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Viemed Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common shares, no par val
August 7, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
August 7, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2024 Viemed Healthcare, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2024 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
August 7, 2024	EX-99.1	VIEMED HEALTHCARE ANNOUNCES RECORD SECOND QUARTER 2024 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES RECORD SECOND QUARTER 2024 FINANCIAL RESULTS Lafayette, Louisiana (August 7, 2024) Viemed Healthcare, Inc.
June 6, 2024	EX-10.1	Viemed Healthcare, Inc. 2024 Long Term Incentive Plan. Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 6, 2024.
June 6, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2024 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm
May 29, 2024	EX-10.1	First Amendment to Credit Agreement dated November 29, 2022, among Viemed Inc. as borrower, certain subsidiaries of Viemed, Inc., as guarantors, the lenders from time to time party thereto, and Regions Bank, as administrative agent and collateral agent, effective May 28, 2024.
May 29, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 May 28, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, In UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 May 28, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
May 9, 2024	EX-99.1	Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD May 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed” or the “Company Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD May 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc.
May 9, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 May 9, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commis
May 6, 2024	EX-99.1	VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS Lafayette, Louisiana (May 6, 2024) Viemed Healthcare, Inc.
May 6, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2024 Viemed Healthcare, In UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2024 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
May 6, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
April 26, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ______________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
April 26, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ______________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State
April 2, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 April 2, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, I UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 April 2, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm
April 2, 2024	EX-99.1	VIEMED ANNOUNCES ACQUISITION OF MAJORITY INTEREST IN HOMEMED, FORGING PARTNERSHIP WITH EAST ALABAMA HEALTH VIEMED ANNOUNCES ACQUISITION OF MAJORITY INTEREST IN HOMEMED, FORGING PARTNERSHIP WITH EAST ALABAMA HEALTH Lafayette, Louisiana (April 2, 2024) Viemed Healthcare, Inc.
March 11, 2024	EX-99.1	Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD March 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed”) is dated as Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD March 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc.
March 11, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 March 11, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
March 6, 2024	EX-21.1	Subsidiaries of the Registrant. EXHIBIT 21.1 List of Subsidiaries Name Jurisdiction of Formation Viemed, Inc. Delaware Home Sleep Delivered, L.L.C. Louisiana Sleep Management, L.L.C. Louisiana Viemed Clinical Services, LLC Louisiana Viemed Healthcare Staffing, LLC Louisiana Viemed Real Estate Holdings, LLC Louisiana Home Medical Products, Inc. Tennessee Schofield Homecare Services, Inc. Alabama Spirocare DME, LLC Tennessee 1
March 6, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa
March 6, 2024	EX-99.1	VIEMED HEALTHCARE ANNOUNCES RECORD 2023 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES RECORD 2023 FINANCIAL RESULTS Lafayette, Louisiana (March 6, 2024) Viemed Healthcare, Inc.
March 6, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2024 Viemed Healthcare, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2024 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
March 6, 2024	EX-97.1	Viemed Healthcare, Inc. Executive Compensation Clawback Policy, as adopted on November 9, 2023. Exhibit 97.1 VIEMED HEALTHCARE, INC. EXECUTIVE COMPENSATION CLAWBACK POLICY 1.OVERVIEW In accordance with the applicable rules of The Nasdaq Stock Market (the “Nasdaq Rules”), Section 10D and Rule 10D-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (“Rule 10D-1”), the Board of Directors (the “Board”) of Viemed Healthcare, Inc. (the “Company”) has adopted this Policy (the
March 6, 2024	EX-4.1	Description of Registrant's Securities. DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description sets forth certain material terms and provisions of the common shares of Viemed Healthcare, Inc.
February 15, 2024	SC 13D/A	VMD / Viemed Healthcare, Inc. / Moore Michael - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.
February 15, 2024	SC 13G/A	VMD / Viemed Healthcare, Inc. / Hoyt Casey - SC 13G/A Passive Investment SC 13G/A 1 sc13gachoyt-2152024.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)1 Viemed Healthcare, Inc. (Name of Issuer) Common Shares, No Par Value (Title of Class of Securities) 92663R105 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box t
February 14, 2024	SC 13G	US92840H4002 / Vistagen Therapeutics, Inc. / Nantahala Capital Management, LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Viemed Healthcare, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 92840H400 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant
February 13, 2024	SC 13G/A	VMD / Viemed Healthcare, Inc. / THRIVENT FINANCIAL FOR LUTHERANS Passive Investment SC 13G/A 1 tfl13ga3viemed.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Viemed Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 92663R105 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th
December 7, 2023	EX-99.1	VIEMED TO CENTRALIZE MARKET FOR COMMON SHARES ON NASDAQ THROUGH VOLUNTARY DELISTING FROM TSX VIEMED TO CENTRALIZE MARKET FOR COMMON SHARES ON NASDAQ THROUGH VOLUNTARY DELISTING FROM TSX Lafayette, Louisiana (December 7, 2023) Viemed Healthcare, Inc.
December 7, 2023	8-K	Regulation FD Disclosure, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 December 7, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C
November 8, 2023	EX-99.1	Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.TO November 2023 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.
November 8, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 November 7, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C
November 1, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2023 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (
November 1, 2023	EX-99.1	VIEMED HEALTHCARE ANNOUNCES RECORD THIRD QUARTER 2023 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES RECORD THIRD QUARTER 2023 FINANCIAL RESULTS Lafayette, Louisiana (November 1, 2023) Viemed Healthcare, Inc.
November 1, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare,
August 31, 2023	CORRESP	August 31, 2023 August 31, 2023 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. Nicholas O’Leary Re: Viemed Healthcare, Inc. Registration Statement on Form S-3 Filed August 24, 2023 File No. 333-274198 Dear Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Viemed Healthcare, Inc. (the
August 24, 2023	EX-FILING FEES	Calculation of Filing Fee Tables (Form Type) Viemed Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Exhibit 107 Calculation of Filing Fee Tables S-3 (Form Type) Viemed Healthcare, Inc.
August 24, 2023	S-3	As filed with the Securities and Exchange Commission on August 24, 2023 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on August 24, 2023 Registration No.
August 10, 2023	EX-99.1	Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.TO August 2023 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed”) Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.
August 10, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 10, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
August 9, 2023	EX-99.1	VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS Lafayette, Louisiana (August 9, 2023) Viemed Healthcare, Inc.
August 9, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 Viemed Healthcare, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
August 9, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
August 2, 2023	EX-99.2	HOME MEDICAL PRODUCTS, INC. AND SUBSIDIARY Jackson, Tennessee Consolidated Financial Statements Year Ended December 31, 2022 HOME MEDICAL PRODUCTS, INC. AND SUBSIDIARY Jackson, Tennessee Consolidated Financial Statements Year Ended December 31, 2022 CONTENTS Independent Auditor's Report 1 – 2 Consolidated Financial Statements Consolidated Balance Sheet 3 Consolidated Statement of Income 4 Consolidated Statement of Shareholder's Equity 5 Consolidated Statement of Cash Flows 6 Notes to Consolidated Financial Statements 7
August 2, 2023	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 2, 2023 (June 1, 2023) Date of Report (Date of earliest UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 2, 2023 (June 1, 2023) Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other
August 2, 2023	EX-99.3	HOME MEDICAL PRODUCTS, INC. Jackson, Tennessee Financial Statements Three Months Ended March 31, 2023 HOME MEDICAL PRODUCTS, INC. Jackson, Tennessee Financial Statements Three Months Ended March 31, 2023 CONTENTS Financial Statements Balance Sheet 1 Statement of Income 2 Statement of Shareholder's Equity 3 Statement of Cash Flows 4 Notes to Financial Statements 5 – 14 HOME MEDICAL PRODUCTS, INC. Balance Sheet March 31, 2023 2023 ASSETS Current assets Cash and cash equivalents $ 310,636 Certificate
August 2, 2023	EX-99.4	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following unaudited pro forma condensed combined financial statements combine the separate historical financial information of Viemed Healthcare, Inc.
June 13, 2023	EX-99.1	VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS Lafayette, Louisiana (June 13, 2023) Viemed Healthcare, Inc.
June 13, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2023 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
June 1, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 June 1, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, In UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 June 1, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
June 1, 2023	EX-99.1	VIEMED ANNOUNCES SUCCESSFUL COMPLETION OF HMP ACQUISITION VIEMED ANNOUNCES SUCCESSFUL COMPLETION OF HMP ACQUISITION Lafayette, Louisiana (June 1, 2023) Viemed Healthcare, Inc.
May 18, 2023	SC 13D/A	VMD / Viemed Healthcare Inc / Moore Michael - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.
May 9, 2023	EX-99	Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.TO May 2023 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed”) is investorpresentationmay2 Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.
May 9, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 May 9, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commis
May 8, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
May 8, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
May 8, 2023	EX-99.1	VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS Lafayette, Louisiana (May 8, 2023) Viemed Healthcare, Inc.
April 28, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ______________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
April 28, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ______________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State
April 19, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 April 18, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 April 18, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
April 19, 2023	EX-2.1	Stock Purchase Agreement dated April 18, 2023 by and among Viemed, Inc., the Stockholders and Home Medical Products, Inc. Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on April 19, 2023. STOCK PURCHASE AGREEMENT BY AND AMONG VIEMED, INC., HOME MEDICAL PRODUCTS, INC., KEVIN ATKINS, individually, as an Equityholder, DAVID STEELE, individually, as an Equityholder, and DAVID STEELE, as the Equityholders’ Representative Dated as of April 18, 2023 TABLE OF CONTENTS Page ARTICLE I SALE AND PURCHASE OF EQUITY 1 1.1. Sale and Purchase of Equity 1 1.2. Purchase Price 2 1.3. Adjustment Amoun
April 19, 2023	EX-99.1	VIEMED ACCELERATES GROWTH THROUGH ACQUISITION OF TENNESSEE BASED HOME MEDICAL PRODUCTS, INC. VIEMED ACCELERATES GROWTH THROUGH ACQUISITION OF TENNESSEE BASED HOME MEDICAL PRODUCTS, INC.
March 3, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 March 3, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, I UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 March 3, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm
March 3, 2023	EX-99.1	Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.TO March 2023 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed”) investorpresentationmarc Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.
March 2, 2023	EX-4.1	Description of Registrant's Securities. DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description sets forth certain material terms and provisions of the common shares of Viemed Healthcare, Inc.
March 2, 2023	EX-21.1	Subsidiaries of the Registrant. EXHIBIT 21.1 List of Subsidiaries Name Jurisdiction of Formation Viemed, Inc. Delaware Home Sleep Delivered, L.L.C. Louisiana Sleep Management, L.L.C. Louisiana Viemed Clinical Services, L.L.C. Louisiana Viemed Healthcare Staffing, L.L.C. Louisiana 1
March 2, 2023	EX-99.1	VIEMED HEALTHCARE ANNOUNCES 2022 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES 2022 FINANCIAL RESULTS Lafayette, Louisiana (March 2, 2023) Viemed Healthcare, Inc.
March 2, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa
March 2, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2023 Viemed Healthcare, UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2023 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
February 21, 2023	SC 13G/A	VMD / Viemed Healthcare Inc / VIEMED HEALTHCARE, INC. - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
February 8, 2023	SC 13G/A	VMD / Viemed Healthcare, Inc. / THRIVENT FINANCIAL FOR LUTHERANS Passive Investment SC 13G/A 1 tfl13gviemed.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Viemed Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 92663R105 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the
January 23, 2023	EX-99.1	VIEMED WINS COMPLETE OVERRULING OF APPEALED OIG CLAIMS RESOLVING MULTIYEAR PROCESS WITH HHS AND CMS VIEMED WINS COMPLETE OVERRULING OF APPEALED OIG CLAIMS RESOLVING MULTIYEAR PROCESS WITH HHS AND CMS Lafayette, Louisiana (January 23, 2023) Viemed Healthcare, Inc.
January 23, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 January 23, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C
January 12, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 January 12, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C
January 12, 2023	EX-99.1	VIEMED ANNOUNCES STRATEGIC INVESTMENT IN POPULATION HEALTH SECTOR VIEMED ANNOUNCES STRATEGIC INVESTMENT IN POPULATION HEALTH SECTOR Lafayette, Louisiana (January 12, 2023) Viemed Healthcare, Inc.
November 29, 2022	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 November 29, 2022 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (
November 29, 2022	EX-10.1	Credit Agreement, dated November 29, 2022, among Viemed, Inc., as borrower, certain subsidiaries of Viemed, Inc., as guarantors, the lenders from time to time party thereto, and Regions Bank, as administrative agent and collateral agent. Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 29, 2022. CREDIT AGREEMENT dated as of November 29, 2022 among VIEMED, INC., as Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER PARTY HERETO FROM TIME TO TIME, as Guarantors, THE LENDERS PARTY HERETO, and REGIONS BANK, as Administrative Agent and Collateral Agent REGIONS CAPITAL MARKETS, a division of Regions Bank, as Sole Lead Arranger and Sole Bookrunner TABLE OF CONTENTS Page Section 1. DEFINITIONS AND IN
November 29, 2022	EX-10.2	Pledge and Security Agreement dated November 29, 2022, among Viemed, Inc., Home Sleep Delivered, L.L.C., Sleep Management, L.L.C., Viemed Clinical Services, LLC, and Viemed Healthcare Staffing LLC, as obligors, and Regions Bank, as collateral agent. Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on November 29, 2022. PLEDGE AND SECURITY AGREEMENT THIS PLEDGE AND SECURITY AGREEMENT (this ?Agreement?) is entered into as of November 29, 2022 among the parties identified as ?Obligors? on the signature pages hereto and such other parties that may become Obligors hereunder after the date hereof (each, an ?Obligor? and collectively, the ?Obligors?), and Regions Bank, in its capacity as collateral agent (in such capacity, the ?Collateral Agent?) for the holders of the Obligations.
November 29, 2022	EX-99.1	VIEMED ANNOUNCES NEW SENIOR SECURED CREDIT FACILITIES VIEMED ANNOUNCES NEW SENIOR SECURED CREDIT FACILITIES Lafayette, Louisiana (November 29, 2022) Viemed Healthcare, Inc.
November 3, 2022	EX-99.1	Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.TO November 2022 Slide 1 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.
November 3, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 November 3, 2022 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C
November 1, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (
November 1, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare,
November 1, 2022	EX-99.1	VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS Lafayette, Louisiana (November 1, 2022) Viemed Healthcare, Inc.
October 18, 2022	SC 13G/A	VMD / Viemed Healthcare, Inc. / THRIVENT FINANCIAL FOR LUTHERANS Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
August 5, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 4, 2022 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
August 5, 2022	EX-99.1	Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.TO August 2022 Slide 1 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“ investorpresenationaugus Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD.
August 2, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
August 2, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
August 2, 2022	EX-99.1	VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS Lafayette, Louisiana (August 2, 2022) Viemed Healthcare, Inc.
August 1, 2022	EX-99.1	VIEMED ANNOUNCES EXECUTIVE ADDITIONS TO LEAD ACQUISITION GROWTH VIEMED ANNOUNCES EXECUTIVE ADDITIONS TO LEAD ACQUISITION GROWTH Lafayette, Louisiana (August 1, 2022) Viemed Healthcare, Inc.
August 1, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 1, 2022 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
July 5, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 July 5, 2022 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
July 5, 2022	EX-99.1	VIEMED ANNOUNCES PUBLICATION OF PEER-REVIEWED NIVH STUDY FINDING TREATMENT REDUCES HEALTHCARE COSTS AND SAVES LIVES VIEMED ANNOUNCES PUBLICATION OF PEER-REVIEWED NIVH STUDY FINDING TREATMENT REDUCES HEALTHCARE COSTS AND SAVES LIVES Lafayette, Louisiana (July 5, 2022) Viemed Healthcare, Inc.
June 28, 2022	SC 13G/A	CA:VMD / Viemed Healthcare Inc / Cove Street Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Viemed Healthcare, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 92663r105 (CUSIP Number) Merihan Tynan 2101 East El Segundo Boulevard. Suite 302 El Segundo, CA 90245 (Name, Address and Telephone Number of Person Author
June 9, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm
June 9, 2022	EX-99.1	VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS Lafayette, Louisiana (June 9, 2022) Viemed Healthcare, Inc.
May 16, 2022	EX-99.1	VIEMED PROVIDES UPDATE CONCERNING SUCCESSFUL APPEAL OF OFFICE OF INSPECTOR GENERAL FINDINGS VIEMED PROVIDES UPDATE CONCERNING SUCCESSFUL APPEAL OF OFFICE OF INSPECTOR GENERAL FINDINGS Lafayette, Louisiana (May 16, 2022) Viemed Healthcare, Inc.
May 16, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm
May 4, 2022	EX-99.1	LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MAY 2022 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the “Presentation”) about VieMed Healthcare, Inc. (“VieMed”) is dated as of May 2022. It LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MAY 2022 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the ?Presentation?) about VieMed Healthcare, Inc.
May 4, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
May 3, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
May 3, 2022	EX-99.1	VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2022 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2022 FINANCIAL RESULTS Lafayette, Louisiana (May 3, 2022) Viemed Healthcare, Inc.
May 3, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
April 29, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ______________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
April 29, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ______________________________________________________________________ DEF 14A 1 a2022def14aproxydoc.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by
March 14, 2022	SC 13G	CA:VMD / Viemed Healthcare Inc / Cove Street Capital, LLC Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. -)* Viemed Healthcare, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 92663r105 (CUSIP Number) Merihan Tynan 2101 East El Segundo Boulevard. Suite 302 El Segundo, CA 90245 (Name, Address and Telephone Number of
March 8, 2022	EX-99.1	VIEMED HEALTHCARE ANNOUNCES SHARE REPURCHASE PROGRAM VIEMED HEALTHCARE ANNOUNCES SHARE REPURCHASE PROGRAM Lafayette, Louisiana (March 8, 2022) Viemed Healthcare, Inc.
March 8, 2022	EX-99.2	LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MARCH 2022 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the “Presentation”) about VieMed Healthcare, Inc. (“VieMed”) is dated as of March 2022. LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MARCH 2022 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the ?Presentation?) about VieMed Healthcare, Inc.
March 8, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
March 7, 2022	EX-21.1	Subsidiaries of the Registrant. EX-21.1 3 exhibit211subsidiariesofth.htm EX-21.1 EXHIBIT 21.1 List of Subsidiaries Name Jurisdiction of Formation Viemed, Inc. Delaware Home Sleep Delivered, L.L.C. Louisiana Sleep Management, L.L.C. Louisiana Viemed Clinical Services, L.L.C. Louisiana Viemed Healthcare Staffing, L.L.C. Louisiana 1
March 7, 2022	EX-99.1	VIEMED HEALTHCARE ANNOUNCES 2021 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES 2021 FINANCIAL RESULTS Lafayette, Louisiana (March 7, 2022) Viemed Healthcare, Inc.
March 7, 2022	EX-4.1	Description of Registrant's Securities. DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description sets forth certain material terms and provisions of the common shares of Viemed Healthcare, Inc.
March 7, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
March 7, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTI UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa
February 17, 2022	SC 13G/A	VMD / Viemed Healthcare, Inc. / Hoyt Casey - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
February 14, 2022	SC 13G	VMD / Viemed Healthcare, Inc. / THRIVENT FINANCIAL FOR LUTHERANS Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
November 3, 2021	EX-99.1	LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / NOVEMBER 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the “Presentation”) about VieMed Healthcare, Inc. (“VieMed”) is dated as of November LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / NOVEMBER 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the ?Presentation?) about VieMed Healthcare, Inc.
November 3, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 November 3, 2021 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C
November 2, 2021	EX-10.1	Form of Restricted Stock Unit Award. Incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on November 2, 2021. RESTRICTED STOCK UNITS AWARD AGREEMENT THIS RESTRICTED STOCK UNITS AWARD AGREEMENT (this ?Agreement?) is made and entered into by and between Viemed Healthcare, Inc.
November 2, 2021	EX-99.1	VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS Lafayette, Louisiana (November 1, 2021) Viemed Healthcare, Inc.
November 2, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (
November 2, 2021	EX-10.2	Non-Employee Directors Deferred Compensation Plan. Incorporated by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed on November 2, 2021. VIEMED HEALTHCARE, INC. NON-EMPLOYEE DIRECTORS DEFERRED COMPENSATION PLAN 1.Purpose. The purpose of the Viemed Healthcare, Inc. Non-Employee Directors Deferred Compensation Plan (the ?Plan?) is to aid the Company in attracting and retaining experienced Non-Employee Directors by providing them with the opportunity to defer receipt, and thus taxation, of the shares of Stock issuable to them under th
November 2, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare,
September 16, 2021	EX-99.1	VIEMED HEALTHCARE ANNOUNCES SECOND PUBLISHED NON-INVASIVE VENTILATION STUDY VIEMED HEALTHCARE ANNOUNCES SECOND PUBLISHED NON-INVASIVE VENTILATION STUDY Lafayette, Louisiana (September 16, 2021) Viemed Healthcare, Inc.
September 16, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 September 16, 2021 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation)
August 6, 2021	EX-99.1	LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / AUGUST 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed”) is dated as of August 202 LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / AUGUST 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the ?Presentation?) about Viemed Healthcare, Inc.
August 6, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 5, 2021 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
August 3, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO S UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
August 2, 2021	EX-99.1	VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS Lafayette, Louisiana (August 2, 2021) Viemed Healthcare, Inc.
August 2, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
June 10, 2021	8-K	Regulation FD Disclosure, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
June 10, 2021	EX-99.1	VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL & SPECIAL MEETING OF SHAREHOLDERS VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL & SPECIAL MEETING OF SHAREHOLDERS Lafayette, Louisiana (June 10, 2021) Viemed Healthcare, Inc.
June 10, 2021	EX-3.1	Amended and Restated Business Corporation Act Articles of Viemed Healthcare, Inc. Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 10, 2021. Number: BC 1100228 BUSINESS CORPORATIONS ACT ARTICLES of VIEMED HEALTHCARE, INC. TABLE OF CONTENTS ARTICLE 1 INTERPRETATION ............................................................................................................................. 1 ARTICLE 2 SHARES AND SHARE CERTIFICATES .......................................................................................... 2 ARTICLE 3 ISSUE
May 24, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm
May 24, 2021	EX-99.1	VIEMED HEALTHCARE COMMENTS ON FINAL REPORT ISSUED BY OFFICE OF INSPECTOR GENERAL VIEMED HEALTHCARE COMMENTS ON FINAL REPORT ISSUED BY OFFICE OF INSPECTOR GENERAL Lafayette, Louisiana (May 24, 2021) Viemed Healthcare, Inc.
May 6, 2021	EX-99.1	LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MAY 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed”) is dated as of May 2021. It EX-99.1 2 vmddeckmay2021.htm EX-99.1 LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MAY 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed”) is dated as of May 2021. It is information in a summary form and does not purport to be complete. The data contained herein is derived from v
May 6, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
May 3, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
May 3, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
May 3, 2021	EX-99.1	VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS Lafayette, Louisiana (May 3, 2021) Viemed Healthcare, Inc.
April 30, 2021	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
April 30, 2021	DEF 14A	- DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
April 9, 2021	PRE 14A	- PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
March 4, 2021	EX-99.1	LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MARCH 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed”) is dated as of March 2021. vmddatemarch2021 LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MARCH 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc.
March 4, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 a8-kmarch2021investordeck.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or o
March 3, 2021	EX-10.23	Form of Restricted Stock Units Agreement. RESTRICTED STOCK UNITS AWARD AGREEMENT THIS RESTRICTED STOCK UNITS AWARD AGREEMENT (this ?Agreement?) is made and entered into by and between Viemed Healthcare, Inc.
March 3, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
March 3, 2021	EX-4.3	Description of Registrant's Securities. DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description sets forth certain material terms and provisions of the common shares of Viemed Healthcare, Inc.
March 3, 2021	EX-10.24	Form of Award Agreement for Stock Option. VIEMED HEALTHCARE, INC. 2020 LONG TERM INCENTIVE PLAN AWARD AGREEMENT FOR A STOCK OPTION This Award Agreement for a Stock Option (?Option Agreement?) is made and entered into as of the Date of Grant set forth in the Notice of Grant of an Award of a Stock Option (?Notice of Grant?) by and between Viemed Healthcare, Inc., a corporation duly incorporated under the laws of the Province of British Colu
March 3, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa
March 3, 2021	EX-99.1	VIEMED HEALTHCARE ANNOUNCES RECORD 2020 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES RECORD 2020 FINANCIAL RESULTS Lafayette, Louisiana (March 3, 2021) Viemed Healthcare, Inc.
February 12, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)1 SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
February 12, 2021	SC 13D	SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2(a) (Amendment No. __)1 SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.
February 11, 2021	EX-99.1	Commonwealth Primary Care ACO and VieMed Healthcare announce an innovative chronic respiratory care and sleep management alliance Commonwealth Primary Care ACO and VieMed Healthcare announce an innovative chronic respiratory care and sleep management alliance VieMed’s clinically proven care model being deployed in Arizona to improve outcomes in patients with impaired respiratory function Lafayette, Louisiana (February 11, 2021) – Viemed Healthcare, Inc.
February 11, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation)
February 9, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Viemed Healthcare, Inc. (Name of Issuer) Common Shares (Title of Class of Securities) (CUSIP Number) Dec SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Viemed Healthcare, Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 92663R105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to
January 7, 2021	EX-99.1	VIEMED HEALTHCARE ANNOUNCES RECENT PUBLICATION OF NON-INVASIVE VENTILATION STUDY VIEMED HEALTHCARE ANNOUNCES RECENT PUBLICATION OF NON-INVASIVE VENTILATION STUDY Lafayette, Louisiana (January 7, 2021) Viemed Healthcare, Inc.
January 7, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C
December 21, 2020	EX-99.1	VIEMED HEALTHCARE ANNOUNCES ENTRY INTO REMOTE PATIENT MONITORING SECTOR VIEMED HEALTHCARE ANNOUNCES ENTRY INTO REMOTE PATIENT MONITORING SECTOR Lafayette, Louisiana (December 21, 2020) Viemed Healthcare, Inc.
December 21, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation)
November 10, 2020	SC 13G	VMD / Viemed Healthcare, Inc. / Moore Michael - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
November 10, 2020	SC 13G	VMD / Viemed Healthcare, Inc. / Hoyt Casey - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.
November 9, 2020	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (
November 9, 2020	EX-99.1	VIEMED HEALTHCARE ANNOUNCES NEW INDEPENDENT BOARD MEMBER VIEMED HEALTHCARE ANNOUNCES NEW INDEPENDENT BOARD MEMBER Lafayette, Louisiana (November 9, 2020) Viemed Healthcare, Inc.
November 6, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (
November 6, 2020	EX-99.1	LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / NOVEMBER 2020 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed”) is dated as of November 2 vmd-deckxnovember2020 LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / NOVEMBER 2020 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc.
November 5, 2020	EX-99.1	VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2020 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2020 FINANCIAL RESULTS Lafayette, Louisiana (November 4, 2020) Viemed Healthcare, Inc.
November 5, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (
November 4, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare,
October 29, 2020	EX-99.1	VIEMED HEALTHCARE COMMENTS ON COMPETITIVE BIDDING PROGRAM VIEMED HEALTHCARE COMMENTS ON COMPETITIVE BIDDING PROGRAM Lafayette, Louisiana (October 28, 2020) Viemed Healthcare, Inc.
October 29, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (
September 8, 2020	CORRESP	- September 8, 2020 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E., Mail Stop 4628 Washington, D.C. 20549 Attention: Ms. Laura Crotty Re: Viemed Healthcare, Inc. Registration Statement on Form S-3 Filed September 3, 2020 File No. 333-248573 Dear Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Viemed Health
September 3, 2020	EX-23.2EXHIBI	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 23.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 of our report dated May 1, 2019, except for note 3, which is as of March 3, 2020, with respect to the consolidated financial statements of Viemed Healthcare, Inc. for the year ended December 31, 2018, included in its Annual Report (Form
September 3, 2020	S-3	- FORM S-3 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on September 3, 2020 Registration No.
August 5, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
August 5, 2020	EX-99.1	VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2020 RECORD FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2020 RECORD FINANCIAL RESULTS Lafayette, Louisiana (August 4, 2020) Viemed Healthcare, Inc.
August 4, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
June 19, 2020	S-8	- S-8 As filed with the Securities and Exchange Commission on June 19, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VIEMED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) British Columbia, Canada N/A (State or Other Jurisdiction of Incorporation or Organization)
June 18, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
June 18, 2020	EX-99.1	VIEMED HEALTHCARE TO JOIN RUSSELL 3000® INDEX VIEMED HEALTHCARE TO JOIN RUSSELL 3000® INDEX Lafayette, Louisiana (June 18, 2020) Viemed Healthcare, Inc.
June 11, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
June 11, 2020	EX-10.1	Viemed Healthcare, Inc. 2020 Long Term Incentive Plan. Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 11, 2020. ex1012020ltincentiveplan
May 27, 2020	EX-99.1	LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MAY 2020 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed”) is dated as of May 2020. It is vmddeckmay2020v2 LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MAY 2020 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc.
May 27, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm
May 19, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
May 6, 2020	EX-99.1	NOTICE OF ANNUAL & SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 11, 2020 AND MANAGEMENT INFORMATION CIRCULAR VIEMED HEALTHCARE, INC. NOTICE OF ANNUAL & SPECIAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that the annual and special meeting ( ex991informationcircular NOTICE OF ANNUAL & SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 11, 2020 AND MANAGEMENT INFORMATION CIRCULAR VIEMED HEALTHCARE, INC.
May 6, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
May 5, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc.
May 5, 2020	EX-10.1	Fourth Amendment to Commercial Business Loan Agreement for Term Loans and Lines of Credit dated May 1, 2020 among Viemed, Inc., Sleep Management, LLC, Home Sleep Delivered, LLC and Hancock Whitney Bank. a101fourthamendment2020 FOURTH AMENDMENT TO COMMERCIAL BUSINESS LOAN AGREEMENT FOR TERM LOANS AND LINES OF CREDIT THIS FOURTH AMENDMENT TO COMMERICAL BUSINESS LOAN AGREEMENT FOR TERM LOANS AND LINES OF CREDIT (this “Fourth Amendment”) is dated May 1, 2020, by and among VIEMED, INC.
May 5, 2020	EX-10.2	Commercial Term Note made by Viemed, Inc., Sleep Management, LLC, Home Sleep Delivered, LLC to Hancock Whitney Bank, dated as of May 1, 2020. a102commercialtermnote20 COMMERCIAL NOTE Lafayette, Louisiana $10,000,000.00 May 1, 2020 For value received, the undersigned maker(s) (hereinafter referred to as "Borrower", which term means individually, collectively, and interchangeably any, each and/or all of them), jointly, severally, and solidarily, promises to pay to the order of HANCOCK WHITNEY BANK ("Bank"), a Mississippi state chartered b
May 4, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi
May 4, 2020	EX-99.1	VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2020 RECORD FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2020 RECORD FINANCIAL RESULTS Lafayette, Louisiana (May 4, 2020) Viemed Healthcare, Inc.
April 28, 2020	10-K/A	Annual Report - 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A Amendment No. 1 x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Hea
April 13, 2020	EX-99.1	VIEMED HEALTHCARE COMMENTS ON COMPETITIVE BIDDING EX-99.1 2 compbiddingexhibit.htm EXHIBIT 99.1 VIEMED HEALTHCARE COMMENTS ON COMPETITIVE BIDDING Lafayette, Louisiana (April 13, 2020) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced that it supports the recent decision by the Centers for Medicare an
April 13, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
April 6, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com
April 6, 2020	EX-99.1	VIEMED HEALTHCARE RAISES FIRST QUARTER GUIDANCE AND PROVIDES UDPATE ON OPERATIONS AND RESPONSE TO COVID-19 VIRUS VIEMED HEALTHCARE RAISES FIRST QUARTER GUIDANCE AND PROVIDES UDPATE ON OPERATIONS AND RESPONSE TO COVID-19 VIRUS Lafayette, Louisiana (April 6, 2020) Viemed Healthcare, Inc.
March 17, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co
March 17, 2020	EX-99.1	VIEMED HEALTHCARE ANNOUNCES RESPONSE TO COVID-19 VIRUS VIEMED HEALTHCARE ANNOUNCES RESPONSE TO COVID-19 VIRUS Lafayette, Louisiana (March 17, 2020) Viemed Healthcare, Inc.
March 4, 2020	EX-4.3	Description of Registrant's Securities. DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description sets forth certain material terms and provisions of the common shares of Viemed Healthcare, Inc.
March 4, 2020	10-K	VMD / Viemed Healthcare, Inc. 10-K - Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa
March 3, 2020	EX-99.1	VIEMED HEALTHCARE ANNOUNCES 2019 RECORD FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES 2019 RECORD FINANCIAL RESULTS Lafayette, Louisiana (March 3, 2020) Viemed Healthcare, Inc.
March 3, 2020	8-K	Financial Statements and Exhibits, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2020 (March 2, 2020) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of inc
January 15, 2020	SC 13G	VIEMF / VIEMED HEALTHCARE INC / Claret Asset Management Corp - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Viemed Healthcare, Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 92663R105 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
November 5, 2019	10-Q	VMD / Viemed Healthcare, Inc. 10-Q - Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare,
November 4, 2019	EX-99.1	VIEMED HEALTHCARE ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER 2019 VIEMED HEALTHCARE ANNOUNCES FINANCIAL RESULTS FOR THIRD QUARTER 2019 Lafayette, Louisiana (November 4, 2019) Viemed Healthcare, Inc.
November 4, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 form8-kq32019earningsrelea.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2019 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State

VMD / Viemed Healthcare, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)

Other Listings